Tourmaline Bio, Inc.
TRML · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $31 | $35 | $31 | $35 |
| Short-Term Investments | $208 | $214 | $228 | $247 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $10 | $9 | $11 | $12 |
| Total Curr. Assets | $249 | $258 | $269 | $294 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $17 | $26 | $37 | $32 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $3 | $3 | $2 |
| Total NC Assets | $20 | $29 | $40 | $35 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $269 | $287 | $309 | $328 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $4 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $5 | $5 | $5 |
| Total Curr. Liab. | $10 | $8 | $9 | $7 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $10 | $8 | $9 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$181 | -$158 | -$135 | -$113 |
| AOCI | $0 | $0 | $0 | $1 |
| Other Equity | $440 | $438 | $435 | $433 |
| Total Equity | $259 | $280 | $300 | $321 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $269 | $287 | $309 | $328 |
| Net Debt | -$31 | -$35 | -$30 | -$35 |